Lymphedema in Endometrial Cancer
| Status: | Completed |
|---|---|
| Conditions: | Cervical Cancer, Cancer, Endometrial Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 6/24/2017 |
| Start Date: | October 2013 |
A Pilot Study of Postoperative Lower-extremity Lymphedema and Quality of Life Among Women Undergoing Endometrial Cancer Staging Surgery
Objectives: (1) To determine the incidence of lower-extremity lymphedema after staging
surgery for endometrial cancer; (2) to describe lymphedema-related morbidity after staging
surgery for endometrial cancer and (3) to evaluate pre- and post-operative quality of life
in women with endometrial cancer who undergo staging surgery.
Data analysis and risk/safety issues: The proposed study will consist of a convenience
sample of women who undergo minimally invasive surgery for endometrial cancer over a 1 year
period. The investigators anticipate enrollment of 75 to 100 women. Frequency tables and
difference with its 95% exact confidence intervals between pre-and post-operative lower
extremity lymphedema measurements and quality of life questionnaires will be estimated.
surgery for endometrial cancer; (2) to describe lymphedema-related morbidity after staging
surgery for endometrial cancer and (3) to evaluate pre- and post-operative quality of life
in women with endometrial cancer who undergo staging surgery.
Data analysis and risk/safety issues: The proposed study will consist of a convenience
sample of women who undergo minimally invasive surgery for endometrial cancer over a 1 year
period. The investigators anticipate enrollment of 75 to 100 women. Frequency tables and
difference with its 95% exact confidence intervals between pre-and post-operative lower
extremity lymphedema measurements and quality of life questionnaires will be estimated.
Inclusion Criteria:
1. women older than 18 years old,
2. endometrial cancer,
3. suitable candidates for surgery,
4. scheduled to undergo laparoscopy or robotic-assisted (RA) laparoscopy for endometrial
cancer at Duke University Medical Center (DUMC),
5. no severe physical or mental comorbidity
Exclusion Criteria:
1. metastatic disease,
2. laparotomy
We found this trial at
1
site
2301 Erwin Rd
Durham, North Carolina 27710
Durham, North Carolina 27710
919-684-8111
Principal Investigator: Laura Havrilesky, MD, MPH
Phone: 919-684-0126
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials
